Key Highlights: Implications: The FTC is allowing Aurobindo’s $250 million Lannett deal only with a divestiture remedy, which should keep competition intact in four generic drug ...
Latest Developments in USFDA Inspections India plays a crucial role in the global pharmaceutical supply chain, supplying a large share of generic medicines to markets around the world. As Indian...
Key Highlights: Implications: Pharma innovators breathe easy as testing bottlenecks vanish, unleashing faster launches for complex biologics and nephrology breakthroughs. Local manufa...
